Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

REALMUTO, Sabrina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.744
EU - Europa 4.772
AS - Asia 3.354
SA - Sud America 540
Continente sconosciuto - Info sul continente non disponibili 335
AF - Africa 122
OC - Oceania 22
Totale 16.889
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.540
IT - Italia 1.476
RU - Federazione Russa 1.117
SG - Singapore 1.071
CN - Cina 862
FI - Finlandia 567
BR - Brasile 395
VN - Vietnam 356
HK - Hong Kong 295
DE - Germania 248
IE - Irlanda 230
PL - Polonia 221
GB - Regno Unito 182
FR - Francia 177
UA - Ucraina 152
KR - Corea 144
JP - Giappone 120
BD - Bangladesh 98
IN - India 94
CA - Canada 86
NL - Olanda 85
BE - Belgio 84
IR - Iran 57
SE - Svezia 45
TR - Turchia 42
MX - Messico 41
AR - Argentina 40
IQ - Iraq 40
RO - Romania 39
ES - Italia 35
CO - Colombia 33
EG - Egitto 33
ID - Indonesia 27
AT - Austria 24
CI - Costa d'Avorio 24
VE - Venezuela 22
AU - Australia 20
EC - Ecuador 20
UZ - Uzbekistan 18
HN - Honduras 17
PK - Pakistan 17
CZ - Repubblica Ceca 15
MA - Marocco 15
CR - Costa Rica 14
GR - Grecia 14
JM - Giamaica 14
KE - Kenya 14
MY - Malesia 14
NP - Nepal 14
LT - Lituania 11
EU - Europa 10
ZA - Sudafrica 10
CL - Cile 9
IL - Israele 9
JO - Giordania 9
SA - Arabia Saudita 9
TW - Taiwan 9
PH - Filippine 8
DK - Danimarca 7
DZ - Algeria 7
PY - Paraguay 7
TH - Thailandia 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
CH - Svizzera 6
MD - Moldavia 6
BO - Bolivia 5
KZ - Kazakistan 5
TT - Trinidad e Tobago 5
GE - Georgia 4
LB - Libano 4
NI - Nicaragua 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
UY - Uruguay 4
AZ - Azerbaigian 3
EE - Estonia 3
ET - Etiopia 3
GT - Guatemala 3
HU - Ungheria 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
PR - Porto Rico 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BS - Bahamas 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
MN - Mongolia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
Totale 16.544
Salva come PNG Salva come JPEG
Città #
Ashburn 1.031
Singapore 681
San Jose 614
Fairfield 517
Chandler 437
Woodbridge 308
Ann Arbor 292
Hong Kong 283
Wilmington 256
Houston 251
Seattle 235
Moscow 229
Dublin 228
Cambridge 176
Zgierz 172
Palermo 159
Council Bluffs 151
Medford 143
New York 137
Beijing 127
Los Angeles 127
Ho Chi Minh City 122
Dallas 115
Des Moines 111
Nanjing 108
Milan 107
Tokyo 107
Boardman 88
Princeton 88
Santa Clara 88
Jacksonville 85
Hanoi 77
Lauterbourg 72
Brussels 71
The Dalles 66
Rome 58
Frankfurt am Main 56
Seoul 55
Altamura 52
Chicago 52
Buffalo 43
Shenyang 43
Tulsa 41
Lawrence 40
Changsha 39
Dearborn 39
San Diego 39
Helsinki 38
São Paulo 35
Phoenix 34
Venice 33
Jinan 32
Orem 32
Nanchang 29
Hebei 28
Toronto 26
Florence 25
Jiaxing 25
London 25
Abidjan 24
Tianjin 24
Naples 23
Nuremberg 23
Verona 23
Amsterdam 22
Tehran 22
Zhengzhou 22
Brooklyn 20
Warsaw 20
Washington 20
Da Nang 19
Montreal 19
Turin 19
Atlanta 17
Baghdad 17
Saint Petersburg 17
Chennai 16
Denver 16
Guangzhou 16
Hangzhou 16
Seongnam 16
Belo Horizonte 15
Brasília 15
Giza 15
Munich 15
Bologna 14
Brno 14
Haiphong 14
New Delhi 14
Ningbo 14
Falls Church 13
Hefei 13
Kumar 13
Ludwigshafen am Rhein 13
Norwalk 13
San José 13
Catania 12
Haikou 12
Istanbul 12
Las Vegas 12
Totale 9.465
Salva come PNG Salva come JPEG
Nome #
Emotion recognition from facial expressions: a normative study of the Ekman 60-Faces Test in the Italian population. 664
Quantitative EEG differentiate Multiple Sclerosis with and without Cognitive Impairment from healthy controls at the beginning of the disease: preliminary data 382
Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients 377
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: A cohort study 308
Effect of extracellular vesicles from CSF of multiple sclerosis patients and healthy controls on astrocytes in culture 292
EARLY AND LATE MORTALITY OF SPONTANEOUS HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE 290
Anodal transcranial direct current stimulation over the right hemisphere improves auditory comprehension in a case of dementia 283
Sleep quality in caregivers of patients with Alzheimer’s disease and Parkinson’s disease and its relationship to quality of life 281
Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study 279
Klotho and vitamin D in multiple sclerosis: an Italian study 275
VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients 275
Application of tRNS to improve multiple sclerosis fatigue: a pilot, single-blind, sham-controlled study 272
A population-based survey of cognitive performance in a Sicilian elderly community. 269
Insidious onset of Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease 268
Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosis: A study of the composition of extracellular vesicles in cerebrospinal fluid 265
The Ekman 60-faces test: an italiana normative study 260
Clinical features, disease course and prognosis in patients with paediatric and young adult onset multiple sclerosis 256
Quantitative EEG differentiates multiple sclerosis with and without cognitive impairment from healthy controls at the beginning of the disease: preliminary data 248
Anodal tDCS of the swallowing motor cortex for treatment of dysphagia in multiple sclerosis: a pilot open-label study 247
Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study 239
DYSAUTONOMIC DYSFUNCTION IN PARKINSON’DISEASE BY SCOPA-AUT SCALE 237
Extracellular vesicles isolated by cerebrospinal fluid as biomarkers of inflammation in multiple sclerosis and inflammatory neurological diseases. 235
Application of tRNS to improve Multiple Sclerosis Fatigue: a sham-controlled study 232
DYSAUTOMIC DISFUNCTON OCCURS EARLY IN PARKINSON DISEASE 217
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study). 214
REM sleep behavior disorder in a patient with frontotemporal dementia 206
Social cognition dysfunctions in patients with epilepsy: Evidence from patients with temporal lobe and idiopathic generalized epilepsies. 204
Lesion Load May Predict Long-Term Cognitive Dysfunction in Multiple Sclerosis Patients 203
Clinical features and disease out come in patients with pediatric and young adult onset Multiple Sclerosis 199
Thalamic stroke mimicking frontotemporal dementia: a case report 198
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers 198
Frequency and clinical features of progranulin mutation carriers in a series of patients affected by frontotemporal lobar de generation: report of a novel mutation 194
IMMUNOSUPPRESSANT TREATMENT AND CANCER RISK IN A COHORT OF PATIENTS AFFECTED BY MULTIPLE SCLEROSIS 192
Frontal dementia related to thalamic stroke: a case report. 191
NEURODEGENERATION IN MULTIPLE SCLEROSIS: COMPARISON BETWEEN CLINICAL, NEUROPSYCHOLOGICAL, MRI,AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS 189
Tumor diagnosis preceding Alzheimer's disease onset: is there a link between cancer and Alzheimer's disease? 185
Frequency of John Cunningham virus (JCV) DNA and of antibodies against JCV in patients affected by multiple sclerosis and their relationship with natalizumab therapy 184
PARKINSON’S DISEASE AND PARKINSON’S DISEASE FAMILIAL HISTORY. RESULTS OF A CASE-CONTROL STUDY 184
Frequency of cognitive impairment and factors associated in outpatients with Parkinson’s disease 182
ELECTROCARDIOGRAPHIC FINDINGS IN PATIENTS WITH DEMENTIA. 177
Modulation of action tremor by repetitive transcranial magnetic stimulation in multiple sclerosis patients 174
Clinical and instrumental predictors of efficacy of natalizumab therapy in the course of multiple sclerosis: a retrospective study from a single centre 172
Quetiapine dose-sparing effect with addiction of memantine: two cases report of Lewy Body disease and dementia associated with Parkinson’s disease 171
PREGNANCIES MODIFY RELAPSES AND PROGRESSION IN MULTIPLE SCLEROSIS 171
Reversible Pisa Syndrome in a patient with Parkinson's Disease on rasagiline therapy 168
Rey-Osterrieth Complex figure performance in patients with degenerative dementia using Boston Qualitative Scoring System 167
Clinical and Instrumental Findings and Disability Progression in Primary Progressive and Progressive Relapsing Multiple Sclerosis: A Comparison Study of a Sicilian Group of Patients 165
Approccio multidimensionale ai disturbi non motori della Malattia di Parkinson 164
Clinical and instrumental predictors of efficacy of Natalizumab therapy in multiple sclerosis patients: a retrospective study from a single centre 163
Frequency of Mitoxantrone related heart involvement in patients affected by Multiple Sclerosis 162
Chronic acquired hepatocerebral degeneration or Parkinson Disease? A case report 162
In patient’s with Parkinson disease, autonomic symptoms are frequent and associated with other non-motor symptoms 162
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 162
PRIMARY PROGRESSIVE CROSSED APHASIA IN A DEXTRAL WOMAN 161
Purine metabolism and Multiple Sclerosis: different pattern according to different disease stage and different clinical form. 161
Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease 159
EXTRACELLULAR VESICLES IN CEREBROSPINAL FLUID AS MARKERS OF CNS INFLAMMATION 155
COGNITIVE IMPAIRMENT IN PATIENTS WITH PARKINSON’S DISEASE 151
RISK FACTORS FOR DYSKINESIAS IN PATIENTS WITH PARKINSON'S DISEASE 146
Back to the life: a case of tretable dementia 145
Heart involvement in patients treated with mitoxantrone for multiple sclerosis 145
Sleep disturbances and dysautonomic dysfunction are associated in patients with Parkinson’s disease 145
Clinical Features and disease outcome in pt with pediatric and young adult onset multiple sclerosis 145
INFLUENCE OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) ON ACTION TREMOR IN MULTIPLE SCLEROSIS PATIENTS 144
Emotion recognition in temporal lobe epilepsy and idiopathic generalized epilepsy 144
Sleep and sleepiness in Parkinson’s disease: result of a “spontaneous” observational study on rotigotine 144
EMpathy ability and emotion recognition in temporal lobe epilepsy and idhiopathic generalizede epileps 142
Primary Progressive and progressive relapsing multiple sclerosis show different clinical and instrumental findings and disability progression? A comparison study on a Sicilian database 139
Return of disease activity after natalizumab therapy discontinuation in patients with multiple sclerosis: frequency and clinical and instrumental predictors of reactivation 138
Sleep quality in caregivers of Parkinson’s disease and Alzheimer’s disease patients and its relationship to quality of life 137
Urinary dysfunction in Parkinson’s disease patients 131
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 127
Toxic effects on astrocytes of extracellular vesicles from CSF of multiple sclerosis patients: A pilot in vitro study 125
Natalizumab therapy of relapsing-remitting multiple sclerosis: an evaluation of the safety profile and a comparison of efficacy with interferon beta therapy 119
Computer-assisted cognitive remediation for Parkinson’s disease 118
Tumor diagnosis preceding Alzheimer’s disease: a case-control study 113
Discontinuation of treatment with Natalizumab after 24 courses. Report from spontaneous, observational, prospective study (TYSTOP). 113
Identification of three novel progranulin mutations in a series of patients affected by sporadic and familial frontotemporal lobar de generation. Platform Presentation 112
Psychosis as adverse effect of cholinesterase inhibitors: two case reports of probable Alzheimer disease in treatment with galantamine 109
Primary progressive crossed aphasia in dextrals: report of three cases 108
Natalizumab Discontinuation after the 24th Course: Which Is Way? The TY-STOP Study 106
Mitochondrial DNA TRNACYS mutation in a family with frontotemporal dementia and Parkinson’s disease 101
Treatment of multiple sclerosis patients after 24 Natalizumab doses: a prospective observational study: the TY-STOP 98
Multiple reversibile MR signals in course of Epstein-Barr virus encephalitis 97
Lifestyle factors and multiple sclerosis: a case control study 95
Looking for the best therapeutical stretegy after the 24th natalizumab adiministretion. The TY-STOP study 92
Reduced striatal dopamine transporter binding in posterior cortical atrophy 90
Purine metabolism and multiple sclerosis: pattern varies according to disease stage and clinical form 88
TREATMENT CHOICE AFTER 24 NATALIZUMAB DOSES IN PATIENTS WITH MULTIPLE SCLEROSIS: A PROSPECTIVE OBSERVATIONAL STUDY, THE TY-STOP 80
LATE MORTALITY OF HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE 68
null 44
null 37
null 3
Totale 16.889
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.365
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022669 0 0 0 47 31 43 31 64 105 110 45 193
2022/20231.577 149 184 51 151 272 253 95 125 177 18 84 18
2023/2024817 35 122 37 82 75 143 44 63 17 46 27 126
2024/20251.656 63 96 92 172 109 51 92 96 128 164 244 349
2025/20265.654 489 141 299 387 561 904 724 662 492 519 244 232
2026/20271.519 277 192 810 240 0 0 0 0 0 0 0 0
Totale 16.889